Effect of Abdominal Wall Injections on Abdominal Pain

• Status: Active, not recruiting
• Trial end date: 2025-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Oregon Health and Science University
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Localized abdominal wall pain

• Average daily pain (7-day recall) ≥ 3 on a scale of 0-10

• Suspected abdominal wall etiology for abdominal pain

• Positive Carnett's sign or pain near an incisional site

• 18 years of age or older

Exclusion Criteria:

• Suspected visceral etiology for the abdominal pain

• Severe allergy to lidocaine

• Unwillingness or inability to provide informed consent

• Low probability of follow-up

• Abdominal wall hernia noted at the point of pain

• History of trigger point injections for abdominal pain

• Bleeding disorder

• Pregnancy, incarceration or decisionally impaired